Diamines & Chemicals Limited Converts 2,69,402 Warrants into Equity Shares

2 min read     Updated on 24 Mar 2026, 06:42 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Diamines & Chemicals Limited converted 2,69,402 warrants into equity shares on March 24, 2026, receiving Rs. 11,15,32,428 from eight allottees at Rs. 414 per warrant. The conversion increased the company's paid-up share capital from Rs. 9,78,39,900 to Rs. 10,05,33,920, with total shares rising to 1,00,53,392. Seven promoter entities and one non-promoter participated in the conversion, while 6,36,988 warrants remain pending for conversion within the 18-month timeline from the original October 2024 allotment.

powered bylight_fuzz_icon
35903564

*this image is generated using AI for illustrative purposes only.

Diamines & chemicals Limited has successfully converted 2,69,402 warrants into an equal number of equity shares following board approval on March 24, 2026. The conversion was executed upon receipt of the balance subscription amount from allottees, marking a significant milestone in the company's capital restructuring initiative.

Warrant Conversion Details

The board of directors approved the conversion after receiving Rs. 11,15,32,428 from allottees at Rs. 414 per warrant, representing 75% of the issue price. This conversion stems from the original allotment of 9,06,390 warrants on October 01, 2024, issued at Rs. 138 each with a total value of Rs. 12,50,81,820.

Parameter Details
Warrants Converted 2,69,402
Conversion Price Rs. 414 per warrant
Total Amount Received Rs. 11,15,32,428
Face Value per Share Rs. 10
Issue Price per Warrant Rs. 552

Allottee Distribution

The conversion involved eight allottees, comprising seven promoter entities and one non-promoter investor. The allocation demonstrates significant promoter participation in the warrant conversion process.

Allottee Category Warrants Held Amount Received (Rs.) Shares Allotted Pending Warrants
Amit Mahendrakumar Mehta Promoter 1,42,920 2,95,84,440 71,460 71,460
Cherry A Mehta Promoter 1,35,164 2,79,78,948 67,582 67,582
Mohak Amit Mehta Promoter 81,092 1,67,86,044 40,546 40,546
Harsh Amit Mehta Promoter 73,632 1,52,41,824 36,816 36,816
S Amit Speciality Chemicals Pvt Ltd Promoter 36,500 75,55,500 18,250 18,250
Perfo Chem India Pvt Ltd Promoter 32,391 67,05,144 16,196 16,195
Finorga (India) Pvt Ltd Promoter 25,503 52,79,328 12,752 12,751
Godiawala Tanmay Naimish Non-Promoter 12,300 24,01,200 5,800 6,500
Total 5,39,502 11,15,32,428 2,69,402 2,70,100

Impact on Share Capital

The warrant conversion resulted in a substantial increase in the company's equity base. The paid-up share capital expanded from Rs. 9,78,39,900 to Rs. 10,05,33,920, reflecting the addition of 2,69,402 new equity shares.

Metric Before Conversion After Conversion
Paid-up Capital Rs. 9,78,39,900 Rs. 10,05,33,920
Number of Shares 97,83,990 1,00,53,392
Face Value per Share Rs. 10 Rs. 10

Remaining Warrants and Timeline

Following this conversion, 6,36,988 warrants remain pending for conversion. These warrants can be converted into equity shares upon payment of the balance 75% of the warrant amounts within 18 months from the original allotment date of October 01, 2024. The company has specified that failure to pay the balance amount by the due date will result in forfeiture of the 25% warrant subscription money already paid, with the warrants being cancelled and all associated rights lapsing.

The newly allotted equity shares will rank pari passu with existing equity shares, subject to completion of necessary corporate actions and receipt of listing and trading approvals from the stock exchanges.

Will the remaining 6,36,988 warrants be converted before the April 2026 deadline, and what factors might influence the allottees' decision?

How will the increased equity base and potential dilution from remaining warrant conversions impact Diamines & chemicals' earnings per share and market valuation?

What strategic initiatives or expansion plans does the company intend to fund with the Rs. 11.15 crore raised from this warrant conversion?

Diamines and Chemicals Limited Board Meeting Scheduled for March 24, 2026 to Consider Warrant Conversion

1 min read     Updated on 17 Mar 2026, 04:19 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Diamines and Chemicals Limited has scheduled a board meeting for March 24, 2026, to consider the conversion of warrants into equity shares on a preferential basis. The meeting is being held in compliance with SEBI (LODR) Regulations 2015, with formal notifications sent to BSE and NSE on March 17, 2026. The conversion will follow the original terms of warrant issuance and accommodate warrant holders' exercise of options.

powered bylight_fuzz_icon
35290194

*this image is generated using AI for illustrative purposes only.

Diamines & Chemicals Limited has announced that its board of directors will convene on March 24, 2026, to deliberate on the conversion of warrants into equity shares. The meeting has been scheduled in compliance with regulatory requirements under the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015.

Meeting Details and Purpose

The board meeting is specifically convened to consider and approve the conversion of warrants into equity shares of the company. This conversion will be executed according to the terms established during the initial warrant issuance and will accommodate the exercise of options by warrant holders on a preferential basis.

Meeting Parameter: Details
Date: Tuesday, March 24, 2026
Primary Agenda: Conversion of Warrants into Equity Shares
Basis: Preferential allocation to warrant holders
Regulatory Framework: SEBI (LODR) Regulations 2015

Regulatory Compliance

The company has formally communicated this development to both major stock exchanges where its shares are listed. The notification was sent to BSE Limited and National Stock Exchange of India Limited on March 17, 2026, ensuring full compliance with Regulation 29 and Chapter IV of the SEBI (LODR) Regulations 2015.

Corporate Communication

The official notice was signed by Hemaxi Pawar, Company Secretary (Membership No.: A52581), and digitally authenticated on March 17, 2026. The communication emphasizes the company's commitment to maintaining transparency with regulatory authorities and stakeholders regarding significant corporate actions.

The board meeting may also address other business matters as deemed necessary by the directors, though the primary focus remains on the warrant conversion process.

More News on Diamines & Chemicals